Hubei Guangji Pharmaceutical Co Ltd (000952) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hubei Guangji Pharmaceutical Co Ltd (000952) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥22.38 Million ≈ $3.27 Million USD) by net assets (CN¥963.20 Million ≈ $140.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hubei Guangji Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Hubei Guangji Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 000952 total debt and obligations for a breakdown of total debt and financial obligations.
Hubei Guangji Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hubei Guangji Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
medmix AG
SW:MEDX
|
0.086x |
|
Zhubo Design
SHE:300564
|
-0.028x |
|
Fondul Proprietatea SA
RO:FP
|
N/A |
|
Linhai Co Ltd
SHG:600099
|
0.435x |
|
Gigasolar Materials
TWO:3691
|
-0.036x |
|
Bafang Yunji Intl Co Ltd
TW:2753
|
0.108x |
|
Firan Technology Group Corporation
TO:FTG
|
0.071x |
|
SGL Carbon SE
XETRA:SGL
|
0.033x |
Annual Cash Flow Conversion Efficiency for Hubei Guangji Pharmaceutical Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Hubei Guangji Pharmaceutical Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see Hubei Guangji Pharmaceutical Co Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.08 Billion ≈ $157.48 Million |
CN¥655.36K ≈ $95.90K |
0.001x | +100.57% |
| 2023-12-31 | CN¥1.39 Billion ≈ $203.76 Million |
CN¥-148.96 Million ≈ $-21.80 Million |
-0.107x | -454.02% |
| 2022-12-31 | CN¥1.49 Billion ≈ $218.30 Million |
CN¥45.08 Million ≈ $6.60 Million |
0.030x | -42.24% |
| 2021-12-31 | CN¥1.45 Billion ≈ $212.30 Million |
CN¥75.91 Million ≈ $11.11 Million |
0.052x | -40.15% |
| 2020-12-31 | CN¥1.37 Billion ≈ $199.84 Million |
CN¥119.38 Million ≈ $17.47 Million |
0.087x | -41.54% |
| 2019-12-31 | CN¥964.30 Million ≈ $141.11 Million |
CN¥144.20 Million ≈ $21.10 Million |
0.150x | -43.08% |
| 2018-12-31 | CN¥880.96 Million ≈ $128.91 Million |
CN¥231.44 Million ≈ $33.87 Million |
0.263x | +12.42% |
| 2017-12-31 | CN¥765.24 Million ≈ $111.98 Million |
CN¥178.83 Million ≈ $26.17 Million |
0.234x | -7.80% |
| 2016-12-31 | CN¥659.18 Million ≈ $96.46 Million |
CN¥167.07 Million ≈ $24.45 Million |
0.253x | +490.58% |
| 2015-12-31 | CN¥513.86 Million ≈ $75.19 Million |
CN¥-33.35 Million ≈ $-4.88 Million |
-0.065x | +56.09% |
| 2014-12-31 | CN¥505.45 Million ≈ $73.96 Million |
CN¥-74.69 Million ≈ $-10.93 Million |
-0.148x | -214.15% |
| 2013-12-31 | CN¥735.04 Million ≈ $107.56 Million |
CN¥95.16 Million ≈ $13.92 Million |
0.129x | -8.91% |
| 2012-12-31 | CN¥760.05 Million ≈ $111.22 Million |
CN¥108.02 Million ≈ $15.81 Million |
0.142x | +49.90% |
| 2011-12-31 | CN¥863.60 Million ≈ $126.37 Million |
CN¥81.88 Million ≈ $11.98 Million |
0.095x | +3.11% |
| 2010-12-31 | CN¥839.35 Million ≈ $122.82 Million |
CN¥77.18 Million ≈ $11.29 Million |
0.092x | +408.50% |
| 2009-12-31 | CN¥816.91 Million ≈ $119.54 Million |
CN¥-24.35 Million ≈ $-3.56 Million |
-0.030x | -110.96% |
| 2008-12-31 | CN¥811.28 Million ≈ $118.72 Million |
CN¥220.70 Million ≈ $32.30 Million |
0.272x | -44.85% |
| 2007-12-31 | CN¥673.00 Million ≈ $98.48 Million |
CN¥331.98 Million ≈ $48.58 Million |
0.493x | +87.08% |
| 2006-12-31 | CN¥477.68 Million ≈ $69.90 Million |
CN¥125.95 Million ≈ $18.43 Million |
0.264x | +158.99% |
| 2005-12-31 | CN¥531.76 Million ≈ $77.81 Million |
CN¥54.14 Million ≈ $7.92 Million |
0.102x | +1705.73% |
| 2004-12-31 | CN¥523.19 Million ≈ $76.56 Million |
CN¥-3.32 Million ≈ $-485.42K |
-0.006x | +78.81% |
| 2003-12-31 | CN¥514.56 Million ≈ $75.30 Million |
CN¥-15.40 Million ≈ $-2.25 Million |
-0.030x | -119.91% |
| 2002-12-31 | CN¥506.86 Million ≈ $74.17 Million |
CN¥76.20 Million ≈ $11.15 Million |
0.150x | +426.75% |
| 2001-12-31 | CN¥486.87 Million ≈ $71.24 Million |
CN¥-22.40 Million ≈ $-3.28 Million |
-0.046x | -145.62% |
| 2000-12-31 | CN¥481.54 Million ≈ $70.46 Million |
CN¥48.57 Million ≈ $7.11 Million |
0.101x | -33.92% |
| 1999-12-31 | CN¥449.30 Million ≈ $65.75 Million |
CN¥68.57 Million ≈ $10.03 Million |
0.153x | +291.61% |
| 1998-12-31 | CN¥191.95 Million ≈ $28.09 Million |
CN¥-15.29 Million ≈ $-2.24 Million |
-0.080x | -- |
About Hubei Guangji Pharmaceutical Co Ltd
Hubei Guangji Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical raw materials, pharmaceutical preparations, and feed additives in China and internationally. It also exports its products. The company was founded in 1969 and is based in Wuxue, China.